Company met with FDA last year and were asked to provide further detailed data regarding the composition and mode of action of their compound, as it is a completely new class of antibiotic. This involved further testing and analysis, completed and submitted with the assistance of a consultant company with expertise in polymers. Currently awaiting response from FDA which we are all hoping is the green light for clinical trials.
Today's spike showed keen anticipation. It's good to be holding this one.
Company met with FDA last year and were asked to provide further...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $118.1M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 46.5¢ | 46.5¢ | $2.131K | 4.582K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1263 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 11173 | 5 |
View Market Depth
| Last trade - 12.38pm 04/12/2024 (20 minute delay) ? |
| RCE (ASX) Chart |
